“Splicing factor ASF/SF2 and transcription factor PPAR-gamma cooperate to directly regulate transcription of uncoupling protein-3”. Biochemical and Biophysical Research Communications378 (4): 877–82. (Jan 2009). doi:10.1016/j.bbrc.2008.12.009. PMID19073146.
“Inactivation of the SR protein splicing factor ASF/SF2 results in genomic instability”. Cell122 (3): 365–78. (Aug 2005). doi:10.1016/j.cell.2005.06.008. PMID16096057.
“Chromosomal localization of mouse and human genes encoding the splicing factors ASF/SF2 (SFRS1) and SC-35 (SFRS2)”. Genomics29 (1): 70–9. (Sep 1995). doi:10.1006/geno.1995.1216. PMID8530103.
“The essential pre-mRNA splicing factor SF2 influences 5' splice site selection by activating proximal sites”. Cell62 (1): 35–42. (Jul 1990). doi:10.1016/0092-8674(90)90237-9. PMID2364434.
“The splicing factor SF2/ASF regulates translation initiation by enhancing phosphorylation of 4E-BP1”. Molecular Cell30 (2): 179–89. (Apr 2008). doi:10.1016/j.molcel.2008.03.013. PMID18439897.
“Factors associated with a purine-rich exonic splicing enhancer sequence in Xenopus oocyte nucleus”. Biochemical and Biophysical Research Communications359 (3): 580–5. (Aug 2007). doi:10.1016/j.bbrc.2007.05.144. PMID17548051.
“Characterization of regulatory intronic and exonic sequences involved in alternative splicing of scavenger receptor class B gene”. Biochemical and Biophysical Research Communications372 (1): 173–8. (Jul 2008). doi:10.1016/j.bbrc.2008.05.007. PMID18477479.
“Ordered multi-site phosphorylation of the splicing factor ASF/SF2 by SRPK1”. Journal of Molecular Biology376 (1): 55–68. (Feb 2008). doi:10.1016/j.jmb.2007.08.029. PMID18155240.
“Efficiency of the pioneer round of translation affects the cellular site of nonsense-mediated mRNA decay”. Molecular Cell29 (2): 255–62. (Feb 2008). doi:10.1016/j.molcel.2007.12.009. PMID18243119.
“Cell motility is controlled by SF2/ASF through alternative splicing of the Ron protooncogene”. Molecular Cell20 (6): 881–90. (Dec 2005). doi:10.1016/j.molcel.2005.10.026. PMID16364913.
“Dephosphorylation-dependent sorting of SR splicing factors during mRNP maturation”. Molecular Cell20 (3): 413–25. (Nov 2005). doi:10.1016/j.molcel.2005.09.015. PMID16285923.
“Increased expression of splicing factor SRp20 mRNA in bipolar disorder patients”. Journal of Affective Disorders110 (1–2): 62–9. (Sep 2008). doi:10.1016/j.jad.2008.01.003. PMID18281098.
“SF2/ASF binds to a splicing enhancer in the third HIV-1 tat exon and stimulates U2AF binding independently of the RS domain”. Journal of Molecular Biology312 (4): 649–62. (Sep 2001). doi:10.1006/jmbi.2001.4971. PMID11575921.
“Alternative splicing factor/splicing factor 2 (ASF/SF2) regulates the expression of T cell receptor ζ chain”. Clinical Immunology127: S95. (2008). doi:10.1016/j.clim.2008.03.266.
“SRPK1 and Clk/Sty protein kinases show distinct substrate specificities for serine/arginine-rich splicing factors”. The Journal of Biological Chemistry271 (40): 24569–75. (Oct 1996). doi:10.1074/jbc.271.40.24569. PMID8798720.
“Effect of cisplatin treatment on speckled distribution of a serine/arginine-rich nuclear protein CROP/Luc7A”. Biochemical and Biophysical Research Communications301 (2): 324–9. (Feb 2003). doi:10.1016/s0006-291x(02)03017-6. PMID12565863.
“The subcellular localization of SF2/ASF is regulated by direct interaction with SR protein kinases (SRPKs)”. The Journal of Biological Chemistry274 (16): 11125–31. (Apr 1999). doi:10.1074/jbc.274.16.11125. PMID10196197.
“The RNA splicing factor ASF/SF2 inhibits human topoisomerase I mediated DNA relaxation”. Journal of Molecular Biology322 (4): 677–86. (Sep 2002). doi:10.1016/s0022-2836(02)00815-x. PMID12270705.
“A serine/arginine-rich domain in the human U1 70k protein is necessary and sufficient for ASF/SF2 binding”. The Journal of Biological Chemistry273 (32): 20629–35. (Aug 1998). doi:10.1074/jbc.273.32.20629. PMID9685421.
“Inactivation of the SR protein splicing factor ASF/SF2 results in genomic instability”. Cell122 (3): 365–78. (Aug 2005). doi:10.1016/j.cell.2005.06.008. PMID16096057.
“Chromosomal localization of mouse and human genes encoding the splicing factors ASF/SF2 (SFRS1) and SC-35 (SFRS2)”. Genomics29 (1): 70–9. (Sep 1995). doi:10.1006/geno.1995.1216. PMID8530103.
“The essential pre-mRNA splicing factor SF2 influences 5' splice site selection by activating proximal sites”. Cell62 (1): 35–42. (Jul 1990). doi:10.1016/0092-8674(90)90237-9. PMID2364434.
“The splicing factor SF2/ASF regulates translation initiation by enhancing phosphorylation of 4E-BP1”. Molecular Cell30 (2): 179–89. (Apr 2008). doi:10.1016/j.molcel.2008.03.013. PMID18439897.
“Factors associated with a purine-rich exonic splicing enhancer sequence in Xenopus oocyte nucleus”. Biochemical and Biophysical Research Communications359 (3): 580–5. (Aug 2007). doi:10.1016/j.bbrc.2007.05.144. PMID17548051.
“Characterization of regulatory intronic and exonic sequences involved in alternative splicing of scavenger receptor class B gene”. Biochemical and Biophysical Research Communications372 (1): 173–8. (Jul 2008). doi:10.1016/j.bbrc.2008.05.007. PMID18477479.
“Ordered multi-site phosphorylation of the splicing factor ASF/SF2 by SRPK1”. Journal of Molecular Biology376 (1): 55–68. (Feb 2008). doi:10.1016/j.jmb.2007.08.029. PMID18155240.
“Efficiency of the pioneer round of translation affects the cellular site of nonsense-mediated mRNA decay”. Molecular Cell29 (2): 255–62. (Feb 2008). doi:10.1016/j.molcel.2007.12.009. PMID18243119.
“Cell motility is controlled by SF2/ASF through alternative splicing of the Ron protooncogene”. Molecular Cell20 (6): 881–90. (Dec 2005). doi:10.1016/j.molcel.2005.10.026. PMID16364913.
“Dephosphorylation-dependent sorting of SR splicing factors during mRNP maturation”. Molecular Cell20 (3): 413–25. (Nov 2005). doi:10.1016/j.molcel.2005.09.015. PMID16285923.
“Increased expression of splicing factor SRp20 mRNA in bipolar disorder patients”. Journal of Affective Disorders110 (1–2): 62–9. (Sep 2008). doi:10.1016/j.jad.2008.01.003. PMID18281098.
“SF2/ASF binds to a splicing enhancer in the third HIV-1 tat exon and stimulates U2AF binding independently of the RS domain”. Journal of Molecular Biology312 (4): 649–62. (Sep 2001). doi:10.1006/jmbi.2001.4971. PMID11575921.
“SRPK1 and Clk/Sty protein kinases show distinct substrate specificities for serine/arginine-rich splicing factors”. The Journal of Biological Chemistry271 (40): 24569–75. (Oct 1996). doi:10.1074/jbc.271.40.24569. PMID8798720.
“Effect of cisplatin treatment on speckled distribution of a serine/arginine-rich nuclear protein CROP/Luc7A”. Biochemical and Biophysical Research Communications301 (2): 324–9. (Feb 2003). doi:10.1016/s0006-291x(02)03017-6. PMID12565863.
“The subcellular localization of SF2/ASF is regulated by direct interaction with SR protein kinases (SRPKs)”. The Journal of Biological Chemistry274 (16): 11125–31. (Apr 1999). doi:10.1074/jbc.274.16.11125. PMID10196197.
“The RNA splicing factor ASF/SF2 inhibits human topoisomerase I mediated DNA relaxation”. Journal of Molecular Biology322 (4): 677–86. (Sep 2002). doi:10.1016/s0022-2836(02)00815-x. PMID12270705.
“A serine/arginine-rich domain in the human U1 70k protein is necessary and sufficient for ASF/SF2 binding”. The Journal of Biological Chemistry273 (32): 20629–35. (Aug 1998). doi:10.1074/jbc.273.32.20629. PMID9685421.